167 related articles for article (PubMed ID: 35023906)
1. Weight Change and the Association with Adherence and Persistence to Diabetes Therapy: A Narrative Review.
Boye KS; Shinde S; Kennedy-Martin T; Robinson S; Thieu VT
Patient Prefer Adherence; 2022; 16():23-39. PubMed ID: 35023906
[TBL] [Abstract][Full Text] [Related]
2. Treatment-Related Attributes of Diabetes Therapies and How People with Type 2 Diabetes Report Their Impact on Indicators of Medication-Taking Behaviors.
Sims TJ; Boye KS; Robinson S; Kennedy-Martin T
Patient Prefer Adherence; 2022; 16():1919-1939. PubMed ID: 35958887
[TBL] [Abstract][Full Text] [Related]
3. Higher Rates of Persistence and Adherence in Patients with Type 2 Diabetes Initiating Once-Weekly vs Daily Injectable Glucagon-Like Peptide-1 Receptor Agonists in US Clinical Practice (STAY Study).
Polonsky WH; Arora R; Faurby M; Fernandes J; Liebl A
Diabetes Ther; 2022 Jan; 13(1):175-187. PubMed ID: 34918213
[TBL] [Abstract][Full Text] [Related]
4. Association of Weight Loss and Medication Adherence Among Adults With Type 2 Diabetes Mellitus: SHIELD (Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes).
Grandy S; Fox KM; Hardy E;
Curr Ther Res Clin Exp; 2013 Dec; 75():77-82. PubMed ID: 24465048
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis of studies examining medication adherence, persistence, and discontinuation of oral antihyperglycemic agents in type 2 diabetes.
Iglay K; Cartier SE; Rosen VM; Zarotsky V; Rajpathak SN; Radican L; Tunceli K
Curr Med Res Opin; 2015; 31(7):1283-96. PubMed ID: 26023805
[TBL] [Abstract][Full Text] [Related]
6. Impact of adherence to antidepressants on healthcare outcomes and costs among patients with type 2 diabetes and comorbid major depressive disorder.
Vega C; Becker RV; Mucha L; Lorenz BH; Eaddy MT; Ogbonnaya AO
Curr Med Res Opin; 2017 Oct; 33(10):1879-1889. PubMed ID: 28644095
[TBL] [Abstract][Full Text] [Related]
7. Comparison of medication adherence and persistence in type 2 diabetes: A systematic review and meta-analysis.
McGovern A; Tippu Z; Hinton W; Munro N; Whyte M; de Lusignan S
Diabetes Obes Metab; 2018 Apr; 20(4):1040-1043. PubMed ID: 29135080
[TBL] [Abstract][Full Text] [Related]
8. Liraglutide Versus Exenatide Once Weekly: Persistence, Adherence, and Early Discontinuation.
Yu M; Xie J; Fernandez Lando L; Kabul S; Swindle RW
Clin Ther; 2016 Jan; 38(1):149-60. PubMed ID: 26706658
[TBL] [Abstract][Full Text] [Related]
9. One in Seven Insulin-Treated Patients in Developing Countries Reported Poor Persistence with Insulin Therapy: Real World Evidence from the Cross-Sectional International Diabetes Management Practices Study (IDMPS).
Chan JCN; Gagliardino JJ; Ilkova H; Lavalle F; Ramachandran A; Mbanya JC; Shestakova M; Dessapt-Baradez C; Chantelot JM; Aschner P
Adv Ther; 2021 Jun; 38(6):3281-3298. PubMed ID: 33978906
[TBL] [Abstract][Full Text] [Related]
10. Injectable Antihyperglycemics: A Systematic Review and Critical Analysis of the Literature on Adherence, Persistence, and Health Outcomes.
Hamersky CM; Fridman M; Gamble CL; Iyer NN
Diabetes Ther; 2019 Jun; 10(3):865-890. PubMed ID: 31054132
[TBL] [Abstract][Full Text] [Related]
11. Medication adherence to injectable glucagon-like peptide-1 (GLP-1) receptor agonists dosed once weekly vs once daily in patients with type 2 diabetes: A meta-analysis.
Weeda ER; Muraoka AK; Brock MD; Cannon JM
Int J Clin Pract; 2021 Sep; 75(9):e14060. PubMed ID: 33527605
[TBL] [Abstract][Full Text] [Related]
12. Predictors of medication adherence in patients with type 2 diabetes mellitus.
Curkendall SM; Thomas N; Bell KF; Juneau PL; Weiss AJ
Curr Med Res Opin; 2013 Oct; 29(10):1275-86. PubMed ID: 23815104
[TBL] [Abstract][Full Text] [Related]
13. Interventions to increase adherence to medications for tobacco dependence.
Hollands GJ; Naughton F; Farley A; Lindson N; Aveyard P
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD009164. PubMed ID: 31425618
[TBL] [Abstract][Full Text] [Related]
14. Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK.
Weiss T; Yang L; Carr RD; Pal S; Sawhney B; Boggs R; Rajpathak S; Iglay K
BMJ Open Diabetes Res Care; 2022 Jan; 10(1):. PubMed ID: 35101924
[TBL] [Abstract][Full Text] [Related]
15. Patient factors associated with diabetes medication adherence at different health literacy levels: a cross-sectional study at a family medicine clinic.
Huang YM; Shiyanbola OO; Chan HY; Smith PD
Postgrad Med; 2020 May; 132(4):328-336. PubMed ID: 32233892
[TBL] [Abstract][Full Text] [Related]
16. Determinants of glycaemic control in a practice setting: the role of weight loss and treatment adherence (The DELTA Study).
McAdam-Marx C; Bellows BK; Unni S; Mukherjee J; Wygant G; Iloeje U; Liberman JN; Ye X; Bloom FJ; Brixner DI
Int J Clin Pract; 2014 Nov; 68(11):1309-17. PubMed ID: 25113816
[TBL] [Abstract][Full Text] [Related]
17. Understanding adherence to medications in type 2 diabetes care and clinical trials to overcome barriers: a narrative review.
Tiktin M; Celik S; Berard L
Curr Med Res Opin; 2016; 32(2):277-87. PubMed ID: 26565758
[TBL] [Abstract][Full Text] [Related]
18. Comparison of adherence and persistence among adults with type 2 diabetes mellitus initiating saxagliptin or linagliptin.
Farr AM; Sheehan JJ; Davis BM; Smith DM
Patient Prefer Adherence; 2016; 10():1471-9. PubMed ID: 27540280
[TBL] [Abstract][Full Text] [Related]
19. Adherence and persistence in patients with type 2 diabetes mellitus newly initiating canagliflozin, dapagliflozin, dpp-4s, or glp-1s in the United States.
Cai J; Divino V; Burudpakdee C
Curr Med Res Opin; 2017 Jul; 33(7):1317-1328. PubMed ID: 28418262
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
